Immunologic Factors

"Immunologic Factors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Biologically active substances whose activities affect or play a role in the functioning of the immune system.

Descriptor ID	D007155
MeSH Number(s)	D27.505.696.477
Concept/Terms	Immunologic Factors Immunologic Factors Immune Factors Factors, Immune Immunological Factors Factors, Immunological Factors, Immunologic Immunomodulators Immunomodulators Biological Response Modifiers Biological Response Modifiers Biomodulators Modifiers, Biological Response Response Modifiers, Biological

Below are MeSH descriptors whose meaning is more general than "Immunologic Factors".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Physiological Effects of Drugs [D27.505.696]
Immunologic Factors [D27.505.696.477]

Below are MeSH descriptors whose meaning is more specific than "Immunologic Factors".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Immunologic Factors" by people in this website by year, and whether "Immunologic Factors" was a major or minor topic of these publications.

Bar chart showing 36 publications over 19 distinct years, with a maximum of 4 publications in 2016 and 2021

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	1	0	1
2004	2	0	2
2005	0	1	1
2007	2	0	2
2008	1	0	1
2009	0	1	1
2010	1	0	1
2011	1	0	1
2013	2	0	2
2014	1	1	2
2015	1	1	2
2016	3	1	4
2018	3	0	3
2019	1	0	1
2020	1	1	2
2021	0	4	4
2022	0	3	3
2023	0	1	1
2024	0	2	2

Below are the most recent publications written about "Immunologic Factors" by people in Profiles.

Ononogbu O, Akindele O, Yazdanfard S, Fatima B, Abughosh S, Trivedi MV. Immunomodulator adherence in multiple myeloma patients with lower socioeconomic status: a retrospective study. Support Care Cancer. 2024 Jun 04; 32(7):407.

View in: PubMed
Rodriguez D, Church KA, Pietramale AN, Cardona SM, Vanegas D, Rorex C, Leary MC, Muzzio IA, Nash KR, Cardona AE. Fractalkine isoforms differentially regulate microglia-mediated inflammation and enhance visual function in the diabetic retina. J Neuroinflammation. 2024 Feb 04; 21(1):42.

View in: PubMed
Deng S, Jin P, Liu S, He Y, Sherchan P, Zhang JH, Gong Y, Tang J. Recruitment of regulatory T cells with rCCL17 promotes M2 microglia/macrophage polarization through TGF?/TGF?R/Smad2/3 pathway in a mouse model of intracerebral hemorrhage. Exp Neurol. 2023 09; 367:114451.

View in: PubMed
Mir H, Singh S. Neutrophils: a roadblock for immunotherapy. Nat Rev Cancer. 2022 07; 22(7):378-379.

View in: PubMed
Zhang J, Tavakoli H, Ma L, Li X, Han L, Li X. Immunotherapy discovery on tumor organoid-on-a-chip platforms that recapitulate the tumor microenvironment. Adv Drug Deliv Rev. 2022 08; 187:114365.

View in: PubMed
Kraveka JM, Lewis EC, Bergendahl G, Ferguson W, Oesterheld J, Kim E, Nagulapally AB, Dykema KJ, Brown VI, Roberts WD, Mitchell D, Eslin D, Hanson D, Isakoff MS, Wada RK, Harrod VL, Rawwas J, Hanna G, Hendricks WPD, Byron SA, Snuderl M, Serrano J, Trent JM, Saulnier Sholler GL. A pilot study of genomic-guided induction therapy followed by immunotherapy with difluoromethylornithine maintenance for high-risk neuroblastoma. Cancer Rep (Hoboken). 2022 11; 5(11):e1616.

View in: PubMed
Dhasmana A, Dhasmana S, Kotnala S, Anukriti A, Kashyap VK, Shaji PD, Laskar P, Khan S, Pellicano R, Fagoonee S, Haque S, Yallapu MM, Chauhan SC, Jaggi M. A topography of immunotherapies against gastrointestinal malignancies. Panminerva Med. 2022 Mar; 64(1):56-71.

View in: PubMed
Zitello E, Hernandez B, Deng Y. Viral Etiology of Solid Tumors and Immunotherapy. Gastroenterology. 2022 02; 162(2):659-660.

View in: PubMed
Del Vecchio F, Martinez-Rodriguez V, Schukking M, Cocks A, Broseghini E, Fabbri M. Professional killers: The role of extracellular vesicles in the reciprocal interactions between natural killer, CD8+ cytotoxic T-cells and tumour cells. J Extracell Vesicles. 2021 04; 10(6):e12075.

View in: PubMed
Chauhan DS, Dhasmana A, Laskar P, Prasad R, Jain NK, Srivastava R, Jaggi M, Chauhan SC, Yallapu MM. Nanotechnology synergized immunoengineering for cancer. Eur J Pharm Biopharm. 2021 Jun; 163:72-101.

View in: PubMed

People

Explore

Similar Concepts

Top Journals